^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    QN-247

    i
    Other names: QN-247, AS1411-GNP, AS1411 plus a DNA-coated gold nanoparticle, Aptamer-Linked Anti-Nucleolin, ALAN
    Associations

    News

    Trials
    Company:
    Qualigen Therap
    Drug class:
    Nucleolin inhibitor
    Related drugs:
    Associations

    News

    Trials
    almost3years
    Nano-immunotherapy: efficacy of nanoconjugate QN-247 in a triple negative breast cancer (TNBC) mouse model (AACR 2023)
    This study demonstrates that QN-247 exerts a powerful anti-tumor effect. Additional preclinical mouse xenograft tumor models will be treated with QN-247 to study its effect on other cancers.
    Preclinical • IO biomarker
    |
    HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor) • NCL (Nucleolin)
    |
    ER expression
    |
    QN-247